Impact of RBP4 polymorphisms on rosiglitazone response in Chinese type 2 diabetes patients
【摘要】:正Objective To explore the association between rs3758539G-803A and rs10882283T-179G polymorphisms of RBP4 and rosiglitazone response in Chinese type 2 diabetes mellitus(T2DM)patients. Methods A total of 472 T2DM patients and 198 healthy subjects wereenrolled to identify G-803A and T-179G genotypes using a polymerase chain reaction-restriction fragment length polymorphism(PCR-RFLP)assay.42 T2DM patients with different G-803A or T-179G genotypes were selected to undergo